299. Cystic fibrosis
1,592 clinical trials,   1,539 drugs   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03435939
(ClinicalTrials.gov)
February 1, 20215/2/2018Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240Anti-Inflammatory Therapy to Augment CFTR Rescue in CF PatientsCystic FibrosisDrug: LosartanUniversity of Kansas Medical CenterNULLNot yet recruiting18 YearsN/AAll16Early Phase 1United States
2NCT03206788
(ClinicalTrials.gov)
November 11, 201729/6/2017Losartan and Inflammation in Cystic FibrosisLosartan as Anti-inflammatory Therapy to Augment F508del Cystic Fibrosis Transmembrane (CFTR) RecoveryCystic FibrosisDrug: Losartan;Drug: placeboUniversity of MiamiUniversity of Alabama at Birmingham;Children's Hospital Medical Center, Cincinnati;University of Kansas Medical Center;Cystic Fibrosis FoundationTerminated12 YearsN/AAll7Phase 2United States